Breast Cancer

Study Reports Benefits Outweigh Burden Of Chemotherapy

Published in Women's Health Weekly, August 30th, 2001

The benefits of adjuvant chemotherapy for breast cancer outweigh its side effects, especially for younger women, conclude authors of a study in the July 28, 2001, issue of the Lancet.

Previous randomized trials have shown that prolonged chemotherapy for breast cancer substantially reduces the risk of disease relapse and death compared with no chemotherapy. However, toxic side effects are a concern because they may result in decreased quality of life for patients; it is therefore important to determine whether the benefits of chemotherapy are sufficient to offset its side effects and justify its use, both overall, and within specific subgroups of patients. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2001-08-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry